Tech Company Financing Transactions
Cancer Prevention Pharmaceuticals Funding Round
On 9/12/2017, Cancer Prevention Pharmaceuticals received $5 million in investment from Sucampo Pharmaceuticals.
Transaction Overview
Company Name
Announced On
9/12/2017
Transaction Type
Debt
Amount
$5,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The additional resources and support from Sucampo will help speed our FAP-310 clinical trial to completion and can offer new hope for treating this unmet medical need.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1760 E. River Rd. 250
Tucson, AZ 85718
USA
Tucson, AZ 85718
USA
Phone
Website
Email Address
Overview
The goal of Cancer Prevention Pharmaceuticals, Inc. (CPP) is to develop prevention therapies for people with elevated risk for cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Jacob
Chief Financial Officer
Christopher Richied
Chief Medical Officer
Alfred Cohen
Chief Scientific Officer
Eugene Gerner
Vice President
Elizabeth Bruckheimer
Browse more venture capital transactions:
Prev: 9/12/2017: Metadata venture capital transaction
Next: 9/12/2017: Kineta venture capital transaction
Share this article
Where The Data Comes From
We do our best to record funding rounds that are announced publicly. VC investment data records reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs